SEC Form 4 · accession 0001140361-26-037237
Grace Therapeutics, Inc. · GRCE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
George Kottayil
Director
Period of report
Sep 17, 2026
Accepted (ET)
Sep 21, 2026 · 4:13 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001444192
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $2.13 | Sep 17, 2026 | A | 12,200 | A | — | Sep 16, 2036 | Common Stock | 12,200 | 12,200 | D |
Explanation of responses
- F150% of this option vests on the date of grant and the remaining 50% vests in substantially equal monthly installments over a 12-month period, subject to the Reporting Person's continuous service as of each vesting date.